617 results on '"Muggeo, M."'
Search Results
2. Type 2 diabetes mellitus: A disease of the governance of the glucose-insulin system: An experimental metabolic control analysis study
3. Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals
4. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes
5. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
6. Serum Lp(a) Levels in Randomized Healthy Men from Different European Countries
7. Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome
8. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
9. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence
10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism
11. Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study
12. Variants and Haplotypes of TCF7L2 Are Associated with β-Cell Function in Patients with Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1
13. Insulin induces tyrosine dephosphorylation of a 92 kDa protein in suspended monocytes
14. Relationship between soluble CD40 ligand and γ-glutamyltransferase concentrations in non-drinking, young Type 1 diabetic individuals
15. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients
16. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
17. Effect of moderate aerobic exercise on sympatho-vagal balance in Type 2 diabetic patients
18. Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study
19. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality
20. type 2 diabetes and chronic liver disease in the Verona diabetes study
21. Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance
22. Long Term Treatment with Pravastatin, Simvastatin and Gemfibrozil in Patients with Primary Hypercholesterolaemia: A Controlled Study
23. Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone
24. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
25. Metabolic Syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study
26. Body mass index and the risk of mortality in type II diabetic patients from Verona
27. Glucose and insulin suppression of plasma free fatty acids in obese subjects with normal glucose tolerance or mild, newly diagnosed Type 2 (non-insulin-dependent) diabetes
28. Predictors of insulin sensitivity in Type 2 diabetes mellitus
29. Assessment of β-cell function during the oral glucose tolerance test by a minimal model of insulin secretion
30. Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist*
31. Relationship Between Insulin and Carotid Atherosclerosis in the General Population: The Bruneck Study
32. Obesity worsens cardiovascular risk profiles independently of hyperinsulinaemia
33. Relationship between fasting insulin and cardiovascular risk factors is already present in young men: the Verona Young Men Atherosclerosis Risk Factors Study
34. DCCT and us: how far are we from implementation?
35. Cardiovascular Disease and Its Risk Factors in IDDM in Europe
36. Plasma factor VII and its relation to adipose tissue fatty acids and other atherogenic risk factors in healthy men
37. Plasma C-peptide response to oral glucose load in hyperthyroidism
38. Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia: the Italian Multicenter Pravastatin Study I
39. Long-term multicentre trial with acipimox in diabetic patients with hyperlipoproteinemia
40. A controlled trial on the hypolipidemic effect of Acipimox in type IIA and IIB hyperlipoproteinemia
41. Measurement of Plasma Catecholamines — Study at Basal and during Insulin-Induced Hypoglycemia in Normal and Diabetic Subjects
42. Glucagon and Hypertriglyceridemia
43. Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study
44. Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study
45. Eighth annual meeting of the European Association for the Study of Diabetes: Madrid, Spain September, 6–8, 1972
46. Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group
47. Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
48. Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study
49. Erratum to: Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
50. Spironolactone prevents the osteopenic effect of hypoestrogenism induced by GNRH-agonist administration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.